Novotech Secures New Investment from GIC and Temasek

Deal News | Mar 31, 2025 | TPG

Novotech Secures New Investment from GIC and Temasek

In a significant move, Novotech, a globally recognized full-service biotech specialist clinical research organization, announced the acquisition of a significant stake by affiliates of GIC and Temasek. This investment, complemented by the reinvestment of TPG through its TPG Asia fund, is poised to accelerate Novotech's global growth. The capital infusion is targeted at enhancing Novotech's reach beyond the APAC region into global markets by supporting organic initiatives and mergers and acquisitions (M&A). GIC's Chief Investment Officer of Private Equity, Choo Yong Cheen, expressed satisfaction at supporting Novotech's next phase of growth alongside TPG, leveraging long-term capital and a global network. The strategic emphasis is placed on driving sustained growth through both organic initiatives and M&A activities.

Sectors

  • Biotechnology
  • Private Equity and Venture Capital
  • Pharmaceuticals

Geography

  • Singapore – Both GIC and Temasek, two of the key investors, are based in Singapore.
  • Sydney, Australia – Novotech is likely headquartered or significantly present in Sydney, evidenced by the press release location.

Industry

  • Biotechnology – As a clinical research organization specializing in biotech, Novotech is a part of the Biotechnology industry.
  • Private Equity and Venture Capital – GIC, Temasek, and TPG are major participants in the private equity and venture capital sectors, driving investments in companies like Novotech.
  • Pharmaceuticals – Novotech's role as a clinical research organization servicing biopharma clients ties it to the Pharmaceuticals sector.

Financials

    Participants

    NameRoleTypeDescription
    NovotechTarget CompanyCompanyA globally recognized full-service biotech specialist clinical research organization.
    GICInvestorCompanySingapore-based sovereign wealth fund investing in Novotech to support its global expansion.
    TemasekInvestorCompanySingaporean investment company participating in funding for Novotech's growth.
    TPGExisting InvestorCompanyA leading global private investment firm reinvesting in Novotech through its TPG Asia fund.
    Choo Yong CheenChief Investment Officer of Private EquityPersonChief Investment Officer of Private Equity at GIC, involved in supporting Novotech's growth.